Show simple item record

dc.contributor.authorManu, Thaddeus
dc.date.accessioned2016-04-07T09:39:46Z
dc.date.available2016-04-07T09:39:46Z
dc.date.issued2014
dc.identifier.citationManu , T 2014 , ' Exploring a regional pharmaceutical innovation network as a possible solution to the market failure in the innovation of essential medicines for tropical diseases in sub-Saharan Africa ' African Journal of Science, Technology, Innovation and Development , vol. 6 , no. 2 , pp. 111-125 . https://doi.org/10.1080/20421338.2014.931742
dc.identifier.issn2042-1346
dc.identifier.otherPURE: 9666749
dc.identifier.otherPURE UUID: 6b9e1381-216d-4ca0-98bb-775e71d95ac9
dc.identifier.otherScopus: 85035226895
dc.identifier.urihttp://hdl.handle.net/2299/17021
dc.description.abstractFrom an economic reasoning perspective, pharmaceutical research and development operates as a pure market activity. This viewpoint suggests innovations are receptive to questions of commerce. It is on this basis the pharmaceutical industry has undervalued the innovation of medicines for diseases that disproportionately affect the poor. Nevertheless, this fundamental thinking overlaps with a social norms standpoint, which dictates that pharmaceutical companies have a moral duty to classify the innovation of medicines for the poor as humanitarian goods as opposed to economic commodities. Notwithstanding the advancement of key social norms to that effect, the lack of innovative medicines for the treatment of tropical diseases is still not a realistic proposition. It is with this complexity in mind this article explores the feasibility of a regional pharmaceutical innovation network as a possible solution to the market failure in the innovation of essential medicines for the treatment of tropical diseases in sub-Saharan Africa. Consequently, it is argued that sub-Saharan African countries must intervene to collectively fund domestic pharmaceutical innovation through a regional network, given that the current global economic arrangement makes it challenging for the pharmaceutical industry to innovate medicines for the treatment of tropical diseases without the prospect of recouping costs of investmentsen
dc.language.isoeng
dc.relation.ispartofAfrican Journal of Science, Technology, Innovation and Development
dc.titleExploring a regional pharmaceutical innovation network as a possible solution to the market failure in the innovation of essential medicines for tropical diseases in sub-Saharan Africaen
dc.contributor.institutionHertfordshire Law School
dc.description.statusPeer reviewed
dc.relation.schoolHertfordshire Law School
rioxxterms.versionofrecordhttps://doi.org/10.1080/20421338.2014.931742
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue
herts.rights.accesstyperestrictedAccess


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record